AUS
NZ
UK
CA
USA
IND
Healthcare
Recce Pharmaceuticals’ Innovative Topical Gel Shows Strong Burn Wound Recovery Results
August 12, 2025 04:13 PM AEST| By Team Kalkine MediaHighlights,New topical gel demonstrates strong results in infection control,Study shows improved healing rates in burn wound models,Backed by a US Department of Defense research program,Recce Pharmaceuticals Ltd (ASX:RCE) has shared new pre-clinical...
Tryptamine Strengthens Clinical Pathway with New R&D Facility Funding
August 12, 2025 04:08 PM AEST| By Team Kalkine MediaHighlights,Secures multi-million-dollar R&D loan facility,Advancing world-first Binge Eating Disorder trial,Exploring wider clinical applications for psilocin therapy,Tryptamine Therapeutics Ltd (ASX:TYP) has expanded its financial capacity through a...
Prescient Therapeutics Moves Ahead with Funding to Boost Cancer Therapy Development
August 12, 2025 11:28 AM AEST| By Team Kalkine MediaHighlights,Prescient Therapeutics progresses with latest funding round,Funds directed toward PTX-100 clinical advancements,Global trial participation continues for CTCL treatment,Prescient Therapeutics Ltd (ASX:PTX), a clinical-stage oncology company...
Anteris Technologies Advances Global Clinical Program for DurAVR® THV
August 12, 2025 11:24 AM AEST| By Team Kalkine MediaHighlights,Clinical adoption expands for DurAVR® THV,Milestone achievement with world-first dual valve procedure,Preparations progress for pivotal PARADIGM Trial,Anteris Technologies Ltd (ASX:AVR) reported steady progress in the second quarter of 202...
Imugene Extends SPP Deadline Amid Clinical Trial Progress
August 12, 2025 11:13 AM AEST| By Team Kalkine MediaHighlights,Extended SPP closing date to provide more participation time,Strong trial results for lead CAR T-cell therapy program,Expanded trial to cover new lymphoma subtypes,Imugene Ltd (ASX:IMU) has announced an extension to its Share Purchase Plan...
ASX 200 Ansell (ASX:ANN) momentum within materials and healthcare
August 11, 2025 05:43 PM AEST| By Team Kalkine MediaHighlights,Share price resilience aligns with broader sentiment despite earnings softness for (ASX:ANN),Total return benefits from distributions add to long horizon outcomes,Insider on-market activity and revenue shifts shape the narrative without al...
Noxopharm Moves HERACLES Trial Forward as Sofra Platform Expands Reach
August 11, 2025 12:35 PM AEST| By Team Kalkine MediaHighlights,HERACLES trial progresses with next dosing stage approved,Sofra platform demonstrates adaptability in immune and cancer research,Collaboration advances towards animal model studies,Noxopharm (ASX:NOX) has taken another step forward in its...
ASX:RMD Share Price: Healthcare Leader Gains Investor Attention in ASX 200
August 11, 2025 10:49 AM AEST| By Team Kalkine MediaHighlights,ResMed (RMD) delivers innovative respiratory care solutions worldwide,Strong presence across medical devices and healthcare technology,Global operations supporting long-term growth trends,ResMed (ASX:RMD), a member of the,ASX 200,, stands...
Pro Medicus (ASX:PME) Shows Steady Growth Momentum Within the ASX 200
August 09, 2025 03:44 PM AEST| By Team Kalkine MediaHighlights,Strong track record in medical imaging software innovation,Solid financial footing with healthy balance sheet,Consistent upward revenue and profit trends,Pro Medicus (ASX:PME) is a specialist in radiology IT solutions, delivering advanced...
Exploring CSL (ASX:CSL) Shares: Insights from the ASX 200 Healthcare Sector
August 08, 2025 06:10 PM AEST| By Team Kalkine MediaHighlights,CSL operates across global healthcare segments with diverse offerings,Healthcare stocks often show resilient demand across market cycles,CSL is part of the ASX 200, reflecting its scale and significance,CSL’s Role in the Global Healthcare...
ASX 300 Percheron Therapeutics progresses with new cancer treatment developments
August 08, 2025 03:38 PM AEST| By Team Kalkine MediaHighlights,Preclinical results indicate tumour growth blockage in triple-negative breast cancer models,Activity observed as a monotherapy, broadening therapeutic scope,Plans to advance towards phase two clinical trials after phase one data release,Pe...
CSL Limited ASX 200 Faces Fresh Challenges as US Pharma Tariffs Loom
August 07, 2025 05:14 PM AEST| By Team Kalkine MediaHighlights,New US pharmaceutical tariffs threaten global supply chains and impact Australian exports,CSL Limited (ASX:CSL) may see disruptions due to blood plasma product dependency,Australian authorities monitor implications for the Pharmaceutical B...
Tryptamine Therapeutics advances psilocin study for Binge Eating Disorder Asx 300
August 07, 2025 05:08 PM AEST| By Team Kalkine MediaHighlights,Clinical trial investigates intravenous psilocin therapy for Binge Eating Disorder,Permit secured by Swinburne University for research on controlled substances,Dosing scheduled to begin this quarter following patient screening and supply l...
Understanding the Value of ResMed CDI (ASX:RMD) in 2025
August 07, 2025 12:47 PM AEST| By Team Kalkine MediaHighlights,Focus on ResMed CDI's dual business segments,Financial and operational trends covered,Overview of valuation and market standing,ResMed CDI (ASX:RMD) continues to draw attention among investors in 2025, being part of the,ASX 200 companies,....
Tryptamine Therapeutics Set to Begin Groundbreaking Psilocin Trial for Binge Eating Disorder
August 07, 2025 11:25 AM AEST| By Team Kalkine MediaHighlights,Dosing to start soon for TRP-8803 in clinical study,Focus on safety and therapeutic effects for BED,Study supported by formal regulatory approval,Tryptamine Therapeutics Ltd (ASX:TYP) is progressing with a clinical study evaluating intrave...
Percheron unveils promising data for potential triple-negative breast cancer treatment
August 06, 2025 04:17 PM AEST| By Team Kalkine MediaHighlights,New preclinical findings highlight a treatment prospect targeting VISTA in triple-negative breast cancer,Preclinical results suggest HMBD-002 may suppress tumour growth by modulating immune and growth pathways,Therapeutic potential expands...
ASX SHL Shares: Exploring the Role of Sonic Healthcare in the ASX 100
August 06, 2025 03:52 PM AEST| By Team Kalkine MediaHighlights,Global presence with diversified medical services,Consistent demand in healthcare sector,Ethical and sustainable business appeal,Sonic Healthcare (ASX:SHL) holds a notable position among the,top ASX 100,companies, making it an influential...
Biotech Developments Spotlight Emerging Healthcare Innovators
August 06, 2025 03:37 PM AEST| By Team Kalkine MediaHighlights,Healthcare sector rotation sparks renewed interest in innovation-led biotech companies,Summit Biotech Fund backs advanced therapies targeting cancer, mental health, and immune diseases,ASX-listed life science firms explore scalable treatme...
New Preclinical Insights into HMBD-002 for Triple-Negative Breast Cancer
August 06, 2025 10:27 AM AEST| By Team Kalkine MediaHighlights,New lab results unveiled for HMBD‑002 in TNBC,Focus on VISTA as an immune system target,Broader research underway for multiple cancers,Percheron Therapeutics Ltd (ASX:PER) has shared new laboratory results on its investigational therapy HM...
Telix Pharmaceuticals Experiences Momentum Amid Regulatory Hurdles
August 05, 2025 04:41 PM AEST| By Team Kalkine MediaHighlights,Telix Pharmaceuticals (ASX:TLX) continues to gain traction despite regulatory uncertainties,Recent global product approvals boost commercial prospects for the company,Pipeline progress and reimbursement milestones provide strategic leverag...
Advertise your brand on Kalkine Media